alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Page 1 of 2

IN THE UNITED STATES DISTRICT COURT FOR THE

NORTHERN DISTRICT OF FLORIDA

PENSACOLA DIVISION

ROBERT EARL ROYSTER,

Plaintiff,

vs. CASE NO.: 3:10cv30/LAC/MD

DAVID MORGAN, et al.,

Defendants.

 

O R D E R

This cause comes on for consideration upon the magistrate judge's report and

recommendation dated May 10, 2010. The plaintiff has been furnished a copy of the

report and recommendation and has been afforded an opportunity to file objections

pursuant to Title 28, United States Code, Section 636(b)(1). No objections have been

filed.

Having considered the report and recommendation, I have determined that the

report and recommendation should be adopted.

Accordingly, it is now ORDERED as follows:

1. The magistrate judge's report and recommendation is adopted and

incorporated by reference in this order.

2. Plaintiff’s § 1983 claims against Sheriff Morgan and Daryl Royster, Jr.,

are DISMISSED WITH PREJUDICE under 28 U.S.C. § 1915(e)(2)(B)(ii).

3. Plaintiff’s conspiracyclaims against DeputyKilgrenand DeputyHall are

DISMISSED WITH PREJUDICE under 28 U.S.C. § 1915(e)(2)(B)(ii).

4. Plaintiff’s damages claims against Deputy Kilgren and Deputy Hall

arising from his alleged false arrest are DISMISSED WITHOUT PREJUDICE under 28

U.S.C. § 1915(e)(2)(B)(ii).

5. Plaintiff’s claims for injunctive relief are DISMISSED WITH PREJUDICE

under 28 U.S.C. § 1915(e)(2)(B)(ii).
Page 2 of 2

6. The clerk is directed to close the file.

DONE AND ORDERED this 29 day of July, 2010. th

s/L.A. Collier 

LACEY A. COLLIER

SENIOR UNITED STATES DISTRICT JUDGE

Case No: 3:10cv30/LAC/MD
<TABLE> <S> <C>


<ARTICLE>                     5
<LEGEND>
     (Replace this text with the legend)
</LEGEND>

<S>                             <C>
<PERIOD-TYPE>                   YEAR
<FISCAL-YEAR-END>                              DEC-31-2000
<PERIOD-END>                                   DEC-31-2000
<CASH>                                         806
<SECURITIES>                                   0
<RECEIVABLES>                                  0
<ALLOWANCES>                                   0
<INVENTORY>                                    0
<CURRENT-ASSETS>                               806
<PP&E>                                         80,195
<DEPRECIATION>                                 69,657
<TOTAL-ASSETS>                                 100,463
<CURRENT-LIABILITIES>                          651,064
<BONDS>                                        0
<PREFERRED-MANDATORY>                          0
<PREFERRED>                                    0
<COMMON>                                       27,961
<OTHER-SE>                                     (588,038)
<TOTAL-LIABILITY-AND-EQUITY>                   100,463
<SALES>                                        0
<TOTAL-REVENUES>                               0
<CGS>                                          0
<TOTAL-COSTS>                                  0
<OTHER-EXPENSES>                               0
<LOSS-PROVISION>                               0
<INTEREST-EXPENSE>                             0
<INCOME-PRETAX>                                0
<INCOME-TAX>                                   0
<INCOME-CONTINUING>                            0
<DISCONTINUED>                                 (1,594,908)
<EXTRAORDINARY>                                0
<CHANGES>                                      0
<NET-INCOME>                                   (1,591,908)
<EPS-BASIC>                                    (.06)
<EPS-DILUTED>                                  0



</TABLE>
Case 1:07-cv-02262-WHP Document 6 Filed 04/30/2007 Page 1 of 1
- 0001.tif
- 0002.tif
- 0003.tif
- 0004.tif
- 0005.tif
- 0006.tif
- 0007.tif
- 0008.tif
- 0009.tif
- 0010.tif
- 0011.tif
- 0012.tif
- 0013.tif
- 0014.tif
- 0015.tif
- 0016.tif
- 0017.tif
- 0018.tif
- 0019.tif
- 0020.tif
- 0021.tif
- 0022.tif
- 0023.tif
- 0024.tif
- 0025.tif
- 0026.tif
- 0027.tif
- 0028.tif
- 0029.tif
- 0030.tif
- 0031.tif
- 0032.tif
- 0033.tif
- 0034.tif
- 0035.tif
- 0036.tif
- 0037.tif
- 0038.tif
- 0039.tif
- 0040.tif
- 0041.tif
- 0042.tif
- 0043.tif
- 0044.tif
- 0045.tif
- 0046.tif
- 0047.tif
- 0048.tif
- 0049.tif
- 0050.tif
- 0051.tif
- 0052.tif
- 0053.tif
- 0054.tif
- 0055.tif
- 0056.tif
- 0057.tif
- 0058.tif
- 0059.tif
- 0060.tif
- 0061.tif
- 0062.tif
- 0063.tif
- 0064.tif
- 0065.tif
- 0066.tif
- 0067.tif
- 0068.tif
- 0069.tif
- 0070.tif
- 0071.tif
- 0072.tif
- 0073.tif
- 0074.tif
- 0075.tif
- 0076.tif
- 0077.tif
- 0078.tif
- 0079.tif
- 0080.tif
- 0081.tif
- 0082.tif
- 0083.tif
- 0084.tif
- 0085.tif
- 0086.tif
- 0087.tif
- 0088.tif
- 0089.tif
- 0090.tif
- 0091.tif
- 0092.tif
- 0093.tif
- 0094.tif
- 0095.tif
- 0096.tif
- 0097.tif
- 0098.tif
- 0099.tif
- 0100.tif
- 0101.tif
- 0102.tif
- 0103.tif
- 0104.tif
- 0105.tif
- 0106.tif
- 0107.tif
- 0108.tif
- 0109.tif
- 0110.tif
- 0111.tif
- 0112.tif
- 0113.tif
- 0114.tif
- 0115.tif
- 0116.tif
- 0117.tif
- 0118.tif
- 0119.tif
- 0120.tif
- 0121.tif
- 0122.tif
- 0123.tif
- 0124.tif
- 0125.tif
- 0126.tif
- 0127.tif
- 0128.tif
- 0129.tif
- 0130.tif
- 0131.tif
- 0132.tif
- 0133.tif
- 0134.tif
- 0135.tif
- 0136.tif
- 0137.tif
- 0138.tif
- 0139.tif
- 0140.tif
- 0141.tif
- 0142.tif
- 0143.tif
- 0144.tif
- 0145.tif
- 0146.tif
- 0147.tif
- 0148.tif
- 0149.tif
- 0150.tif
- 0151.tif
- 0152.tif
- 0153.tif
- 0154.tif
- 0155.tif
- 0156.tif
- 0157.tif
- 0158.tif
- 0159.tif
- 0160.tif
- 0161.tif
- 0162.tif
- 0163.tif
- 0164.tif
- 0165.tif
- 0166.tif
- 0167.tif
- 0168.tif
- 0169.tif
- 0170.tif
- 0171.tif
- 0172.tif
- 0173.tif
- 0174.tif
- 0175.tif
- 0176.tif
- 0fm-0001.tif
- 0fm-0002.tif
- 0fm-0003.tif
- 0fm-0004.tif
- 0fm-0005.tif
- 0fm-0006.tif
- 0fm-0007.tif
- 0fm-0008.tif
- 0fm-0009.tif
- 0fm-0010.tif
- 0fm-0011.tif
- 0fm-0012.tif
<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE
REGISTRANT'S CONDENSED CONSOLIDATED BALANCE SHEET AND STATEMENT OF INCOME FOR
THE NINE MONTHS ENDED MARCH 31, 2000 AND IS QUALIFIED IN ITS ENTIRETY BY
REFERENCE TO SUCH FINANCIAL STATEMENTS.
</LEGEND>
<MULTIPLIER> 1,000

<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          JUN-30-2000
<PERIOD-END>                               MAR-31-2000
<CASH>                                           2,187
<SECURITIES>                                         0
<RECEIVABLES>                                  133,512
<ALLOWANCES>                                     8,750
<INVENTORY>                                    166,615
<CURRENT-ASSETS>                               315,927
<PP&E>                                         410,109
<DEPRECIATION>                                 236,814
<TOTAL-ASSETS>                                 533,262
<CURRENT-LIABILITIES>                           85,536
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                        51,951
<OTHER-SE>                                     376,085
<TOTAL-LIABILITY-AND-EQUITY>                   533,262
<SALES>                                        847,615
<TOTAL-REVENUES>                               847,615
<CGS>                                          588,913
<TOTAL-COSTS>                                  588,913
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                               1,503
<INCOME-PRETAX>                                122,524
<INCOME-TAX>                                    46,729
<INCOME-CONTINUING>                             75,795
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                    75,795
<EPS-BASIC>                                       1.90
<EPS-DILUTED>                                     1.90


</TABLE>
EXHIBIT 31.2 

 

**CERTIFICATIONS**

 

I, D. Michael Parker, Senior Vice President, Finance and Chief Financial Officer of Kewaunee Scientific Corporation, certify that: 

 

1. I have reviewed this quarterly report on Form 10-Q of Kewaunee ScientificCorporation; 

 

2. Based on my knowledge, this quarterly reportdoes not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period coveredby this quarterly report; 

 

3. Based on my knowledge, thefinancial statements, and other financial information included in this quarterly report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented inthis quarterly report; 

 

4. The registrant’s othercertifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and we have: 

 

a) designed such disclosure controls and procedures, or caused suchdisclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularlyduring the period in which this quarterly report is being prepared; 

 

b) evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this quarterly report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of periodcovered by this report based on such evaluation; and 

 

c)disclosed in this quarterly report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter that has materially affected, or is reasonably likely tomaterially affect, the registrant’s internal control over financial reporting; 

 

5. The registrant’s other certifying officer and I have disclosed, based on our most recentevaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of registrant’s board of directors (or persons performing the equivalent function): 

 

a) all significant deficiencies and material weaknesses in the design oroperation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and 

 

b) any fraud, whether or not material, that involves management or otheremployees who have a significant role in the registrant’s internal control over financial reporting. 

 

Date: December 15, 2003

 
 /s/    D. MICHAEL PARKER        
**D. Michael Parker**

**Senior Vice President, Finance**

**and Chief Financial Officer**
##### 



EXHIBIT 99.1 COMPANYS OFFICERS CERTIFICATE GRACECHURCH CARD FUNDING (NO. 4) PLC
CERTIFICATE OF COMPLIANCE The undersigned officer of Gracechurch Card Funding (No. 4) PLC, a public
limited company incorporated in England and Wales (the Issuer), hereby
certifies on behalf of the Issuer and on his own behalf for purposes of the
$900,000,000 Class A Floating Rate Asset-Backed Notes, the $50,000,000 Class B
Floating Rate Asset-Backed Notes and the $50,000,000 Class C Floating Rate
Asset-Backed Notes (together, the Notes), as follows:  1.
    
    I am a duly appointed, qualified and acting Director of the Issuer;2.
    
    I am duly authorized to execute and deliver this Officers Certificate on behalf of the Issuer; and3.
    
    To the best of my knowledge, the Issuer has complied with all conditions and covenants under the
Relevant Documents for the issue of Notes for the period between January 1, 2003 and the end of
the Issuers fiscal year on December 31, 2003. Capitalized terms used and not defined herein shall have the meanings assigned
to such terms in the Registration Statement related to the above-referenced
issue of Notes. IN WITNESS WHEREOF, I have signed my name this 21st day of June, 2004. By:
    
    /s/ Richard Francis SommersName: Richard Francis SommersTitle: Director
#### TEXACO v. CREEL

No. 381PA82.

Case below: 57 N.C. App. 611.

Petition by defendants for discretionary review under G.S. 7A-31 allowed 3 August 1982.
Case 7:07-cv-03502-CLB Document 6 Filed 06/27/2007 Page 1 of 4
Case 7:07-cv-03502-CLB Document 6 Filed 06/27/2007 Page 2 of 4
Case 7:07-cv-03502-CLB Document 6 Filed 06/27/2007 Page 3 of 4
Case 7:07-cv-03502-CLB Document 6 Filed 06/27/2007 Page 4 of 4
[Federal Register Volume 72, Number 210 (Wednesday, October 31, 2007)]
[Notices]
[Page 61660]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 07-5392]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute On Drug Abuse; Notice of Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute on Drug Abuse Special 
Emphasis Panel, I/START Review.
    Date: November 9, 2007.
    Time: 1 p.m. to 5 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6101 Executive Boulevard, 
Rockville, MD 20852. (Virtual Meeting)
    Contact Person: Mark Swieter, PhD, Chief, Training and Special 
Projects Review Branch, Office of Extramural Affairs, National 
Institute on Drug Abuse, NIH, DHHS, 6101 Executive Boulevard, Suite 
200, Bethesda, MD 20892-8401, (301) 435-1389, <a href="/cdn-cgi/l/email-protection#ef829cd7df97af818687c1888099"><span class="__cf_email__" data-cfemail="eb8698d3db93ab858283c58c849d">[email protected]</span></a>.
    This notice is being published less than 15 days prior to the 
meeting due to the timing limitations imposed by the review and 
funding cycle.

(Catalogue of Federal Domestic Assistance Program Nos. 93.279, Drug 
Abuse and Addiction Research Programs, National Institutes of 
Health, HHS)

    Dated: October 24, 2007.
Anna Snouffer,
Acting Director, Office of Federal Advisory Committee Policy.
[FR Doc. 07-5392 Filed 10-30-07; 8:45 am]
BILLING CODE 4140-01-M


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
Exhibit 31

CERTIFICATION


I, William E. Luther, certify that:

1. I have reviewed this quarterly report on Form 10-QSB of
   Lescarden Inc., a small business issuer.

2. Based on my knowledge, this report does not contain any untrue
   statement of a material fact or omit to state a material fact
   necessary to make the statements made, in light of the
   circumstances under which such statements were made, not
   misleading with respect to the period covered by this report:

3. Based on my knowledge, the financial statements, and other
   financial information included in this report, fairly present
   in all material respects the financial condition, results of
   operations and cash flows of the small business issuer as of,
   and for, the periods presented in this report;

4. I am responsible for establishing and maintaining disclosure
   controls and procedures (as defined in Exchange Act Rules
   13a - (15(e) and 15d - 15(e)) and internal control over
   financial reporting (as defined in Exchange Act Rules 13a-15(f)
   and 15d-15(f) for the small business issuer and have:

a) Designed such disclosure controls and procedures, or caused such
   disclosure controls and procedures to be designed under my
   supervision, to ensure that material information relating to
   the small business issuer, is made know to me, particularly
   during the period in which this report is being prepared;

c) Evaluated the effectiveness of the small business issuer's
   disclosure controls and procedures and presented in this report
   our conclusions about the effectiveness of the disclosure controls
   and procedures, as of the end of the period covered by this report
   based on such evaluation; and

d) Disclosed in this report any change in the small business issuer's
   internal control over financial reporting that occurred during
   the small business issuer's most recent fiscal quarter (the small
   business issuer's fourth fiscal quarter in the case of an annual
   report) that has materially affected, or is reasonably likely to
   materially affect, the small business issuer's internal control
   over financial reporting; and;

5. I have disclosed, based on my most recent evaluation of internal
   control over financial reporting, to the small business issuer's
   auditors and the audit committee of the small business issuer's
   board of directors (or persons performing the equivalent
   functions):

a) All significant deficiencies and material weaknesses in the design
   or operation of internal control over financial reporting  which
   are reasonably likely to adversely affect the small business
   issuer's ability to record, process, summarize and report financial
   information; and

b) Any fraud, whether or not material, that involves management or
   other employees who have a significant role in the small business
   issuer's internal control over financial reporting.

Date: 	October 6, 2006
	/s/William E. Luther
	Chief Executive Officer and Chief Financial Officer
IN THE UNITED STATES DISTRICT COURT FOR THE

NORTHERN DISTRICT OF FLORIDA

UNITED STATES OF AMERICA

Plaintiff, CASE NO.: 1:10CR12-SPM-AK

VS.

ERIC KIMBLE,

Defendant.

______________________________/

ORDER OF REASSIGNMENT

To effect the timely and efficient handling of issues related to Case No.:

1:10cr12-SPM, this case is hereby reassigned to the Honorable Maurice Paul for all

purposes, it is ORDERED:

 The Clerk shall reassign Case No.: 1:10cr12-SPM to the Honorable Maurice

Paul. 

SO ORDERED this 24th day of March, 2010.

 S/ Stephan P. Mickle 

Stephan P. Mickle

Chief United States District Judge
WARNING: THE EDGAR SYSTEM ENCOUNTERED ERROR(S) WHILE PROCESSING THIS SCHEDULE.

<TABLE> <S> <C>


<PAGE>

<ARTICLE> 5

<S>                                 <C>
<PERIOD-TYPE>                                    3-MOS
<FISCAL-YEAR-END>                          JUN-30-2001
<PERIOD-START>                             JUL-01-2000
<PERIOD-END>                               SEP-30-2000
<CASH>                                         865,265
<SECURITIES>                                         0
<NOTE-RECEIVABLE>                            6,500,000
<RECEIVABLES>                                  694,235
<ALLOWANCES>                                  (36,343)
<INVENTORY>                                     45,812
<CURRENT-ASSETS>                             8,124,753
<PP&E>                                       2,536,787
<DEPRECIATION>                                 668,940
<TOTAL-ASSETS>                              10,050,910
<CURRENT-LIABILITIES>                       11,147,939
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                     1,696,819
<OTHER-SE>                                 (3,566,979)
<TOTAL-LIABILITY-AND-EQUITY>                10,050,910
<SALES>                                      1,792,018
<TOTAL-REVENUES>                             1,792,018
<CGS>                                          976,539
<TOTAL-COSTS>                                2,078,699
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                             126,118
<INCOME-PRETAX>                              (412,799)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                          (412,799)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                 (412,799)
<EPS-BASIC>                                       0.00
<EPS-DILUTED>                                     0.00



</TABLE>
**EXHIBIT 10.4**

 

MODIFICATION TOPROMISSORY NOTE

 

 

WHEREAS,on March 15, 1993, Lee Pharmaceuticals (“Maker”) and Henry L. Lee, Jr.(“Holder”) entered into an agreement (“Note”) whereby Lee Pharmaceuticals wasto pay to Henry L. Lee, Jr. the sum of Three Hundred Seventy One ThousandThree Hundred Thirty Four Dollars; and

 

WHEREAS,on January 18, 1995, the parties thereto modified said Note to extend thematurity date from November 15, 1997, until January 1, 2005, and theNote had an option to extend the maturity date for an additional five yearsbeyond January 1, 2005.  All otherterms and conditions of the Note remained the same.

 

WHEREAS,the parties thereto now desire to further modify said Note and Modification;

 

NOW,THEREFORE, the parties modify said Note and Modification as follows:

 

1.      Thematurity date of the Note is extended from January 1, 2005, until January 1,2010.

 

2.      All otherterms and conditions of the Note remain the same.

 

 

Dated  this  **24th** day  of  **February, 2005**

 

 
| ** ** | **RONALD  G. LEE**            |
|------------|-------------------------------|
|       | Lee Pharmaceuticals           |
|       | By: Ronald G. Lee,  President |
|       |                          |
|       |                          |
| ** ** | **HENRY  L. LEE, JR.**        |
|       | Henry L. Lee, Jr.        |

 

----